新型吡唑-异噁唑类和吡唑-异噁唑类化合物的合成与抗霉菌评价。

IF 2.8 4区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY ChemBioChem Pub Date : 2024-10-05 DOI:10.1002/cbic.202400414
Paulo A. Moraes, Thaise Dill Fussinger, Tuyla Fontana, Genilson S. Pereira, Mário A. Marangoni, Adriano F. Camargo, Helio G. Bonacorso, Marcos A. P. Martins, Alencar K. Machado, Marli M. A. de Campos, Nilo Zanatta
{"title":"新型吡唑-异噁唑类和吡唑-异噁唑类化合物的合成与抗霉菌评价。","authors":"Paulo A. Moraes,&nbsp;Thaise Dill Fussinger,&nbsp;Tuyla Fontana,&nbsp;Genilson S. Pereira,&nbsp;Mário A. Marangoni,&nbsp;Adriano F. Camargo,&nbsp;Helio G. Bonacorso,&nbsp;Marcos A. P. Martins,&nbsp;Alencar K. Machado,&nbsp;Marli M. A. de Campos,&nbsp;Nilo Zanatta","doi":"10.1002/cbic.202400414","DOIUrl":null,"url":null,"abstract":"<p>This study reports the synthesis of a new series of pyrazole-isoxazolines, at very good yields, from the cyclocondensation reaction of pyrazole-enaminones with hydroxylamine hydrochloride. Dehydration of the pyrazole-isoxazolines furnished another new series of the respective pyrazole-isoxazoles, at excellent yields. Both series of the obtained compounds were screened for antimycobacterial activity, and compounds <b>4 f</b> and <b>5 c</b> showed significant inhibition of bacterial growth with a time- and concentration-dependent bactericidal effect. Cytotoxicity tests in VERO cell line did not indicate toxicity of compounds <b>4 f</b> and <b>5 c</b> regarding cellular prediction, NO production or dsDNA release. However, both compounds were associated with an increase in total ROS levels, providing induction of oxidative stress, but without compromising cellular targets. These results highlight compounds <b>4 f</b> and <b>5 c</b> as promising candidates for antimycobacterial treatment with a favorable safety profile.</p>","PeriodicalId":140,"journal":{"name":"ChemBioChem","volume":"25 23","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Synthesis and Antimycobacterial Evaluation of Novel Pyrazole-Isoxazolines and Pyrazole-Isoxazoles\",\"authors\":\"Paulo A. Moraes,&nbsp;Thaise Dill Fussinger,&nbsp;Tuyla Fontana,&nbsp;Genilson S. Pereira,&nbsp;Mário A. Marangoni,&nbsp;Adriano F. Camargo,&nbsp;Helio G. Bonacorso,&nbsp;Marcos A. P. Martins,&nbsp;Alencar K. Machado,&nbsp;Marli M. A. de Campos,&nbsp;Nilo Zanatta\",\"doi\":\"10.1002/cbic.202400414\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>This study reports the synthesis of a new series of pyrazole-isoxazolines, at very good yields, from the cyclocondensation reaction of pyrazole-enaminones with hydroxylamine hydrochloride. Dehydration of the pyrazole-isoxazolines furnished another new series of the respective pyrazole-isoxazoles, at excellent yields. Both series of the obtained compounds were screened for antimycobacterial activity, and compounds <b>4 f</b> and <b>5 c</b> showed significant inhibition of bacterial growth with a time- and concentration-dependent bactericidal effect. Cytotoxicity tests in VERO cell line did not indicate toxicity of compounds <b>4 f</b> and <b>5 c</b> regarding cellular prediction, NO production or dsDNA release. However, both compounds were associated with an increase in total ROS levels, providing induction of oxidative stress, but without compromising cellular targets. These results highlight compounds <b>4 f</b> and <b>5 c</b> as promising candidates for antimycobacterial treatment with a favorable safety profile.</p>\",\"PeriodicalId\":140,\"journal\":{\"name\":\"ChemBioChem\",\"volume\":\"25 23\",\"pages\":\"\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2024-10-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ChemBioChem\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cbic.202400414\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ChemBioChem","FirstCategoryId":"99","ListUrlMain":"https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cbic.202400414","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

本研究报告了由吡唑-烯丙酮与盐酸羟胺的环缩合反应合成的一系列新的吡唑-异恶唑,收率非常高。将吡唑-异恶唑啉脱水后,得到了另一系列新的吡唑-异恶唑,收率极高。对获得的这两个系列的化合物进行了抗霉菌活性筛选,化合物 4f 和 5c 对细菌的生长有显著的抑制作用,其杀菌效果与时间和浓度有关。在 VERO 细胞系中进行的细胞毒性测试表明,化合物 4f 和 5c 在细胞预测、NO 生成或 dsDNA 释放方面没有毒性。不过,这两种化合物都会导致 ROS 总量的增加,从而诱导氧化应激,但不会损害细胞靶标。这些结果突出表明,化合物 4f 和 5c 具有良好的安全性,有望成为抗霉菌治疗的候选化合物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Synthesis and Antimycobacterial Evaluation of Novel Pyrazole-Isoxazolines and Pyrazole-Isoxazoles

This study reports the synthesis of a new series of pyrazole-isoxazolines, at very good yields, from the cyclocondensation reaction of pyrazole-enaminones with hydroxylamine hydrochloride. Dehydration of the pyrazole-isoxazolines furnished another new series of the respective pyrazole-isoxazoles, at excellent yields. Both series of the obtained compounds were screened for antimycobacterial activity, and compounds 4 f and 5 c showed significant inhibition of bacterial growth with a time- and concentration-dependent bactericidal effect. Cytotoxicity tests in VERO cell line did not indicate toxicity of compounds 4 f and 5 c regarding cellular prediction, NO production or dsDNA release. However, both compounds were associated with an increase in total ROS levels, providing induction of oxidative stress, but without compromising cellular targets. These results highlight compounds 4 f and 5 c as promising candidates for antimycobacterial treatment with a favorable safety profile.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
ChemBioChem
ChemBioChem 生物-生化与分子生物学
CiteScore
6.10
自引率
3.10%
发文量
407
审稿时长
1 months
期刊介绍: ChemBioChem (Impact Factor 2018: 2.641) publishes important breakthroughs across all areas at the interface of chemistry and biology, including the fields of chemical biology, bioorganic chemistry, bioinorganic chemistry, synthetic biology, biocatalysis, bionanotechnology, and biomaterials. It is published on behalf of Chemistry Europe, an association of 16 European chemical societies, and supported by the Asian Chemical Editorial Society (ACES).
期刊最新文献
The Hoechst Dye-Binding RNA Aptamer Recognizes Its Ligand in a Highly Dynamic Fashion. Fusion Arrest and Triggered Release of Contents in Coacervates via Oxidation-Assisted Interfacial Coating. Affinity Enhancement in Discrete Multivalent MegaMolecules. The Antidepressant Drug Clomipramine Inhibits the ABC Transporter BmrA. Metal-Dependent Effects and Crowding Robustness of Pseudomonas fluorescens Esterase I.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1